Bank of New York Mellon Corp raised its holdings in shares of National Research Co. (NASDAQ:NRC - Free Report) by 88.5% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 217,212 shares of the company's stock after acquiring an additional 101,957 shares during the period. Bank of New York Mellon Corp owned approximately 0.93% of National Research worth $3,832,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently made changes to their positions in NRC. Hotchkis & Wiley Capital Management LLC bought a new stake in shares of National Research during the 3rd quarter valued at $3,158,000. Algert Global LLC increased its position in shares of National Research by 94.0% in the 3rd quarter. Algert Global LLC now owns 82,921 shares of the company's stock valued at $1,896,000 after buying an additional 40,182 shares in the last quarter. Barclays PLC increased its position in shares of National Research by 65.6% in the 3rd quarter. Barclays PLC now owns 51,331 shares of the company's stock valued at $1,175,000 after buying an additional 20,331 shares in the last quarter. QV Investors Inc. increased its position in shares of National Research by 4.5% in the 4th quarter. QV Investors Inc. now owns 354,360 shares of the company's stock valued at $6,251,000 after buying an additional 15,370 shares in the last quarter. Finally, GSA Capital Partners LLP bought a new stake in shares of National Research in the 3rd quarter valued at $330,000. Institutional investors own 47.26% of the company's stock.
National Research Trading Down 3.7 %
Shares of NRC traded down $0.55 during trading hours on Friday, reaching $14.44. The stock had a trading volume of 143,625 shares, compared to its average volume of 87,914. The company has a quick ratio of 0.47, a current ratio of 0.47 and a debt-to-equity ratio of 1.30. National Research Co. has a 52 week low of $13.74 and a 52 week high of $40.65. The firm has a 50-day moving average of $16.24 and a 200 day moving average of $18.34. The company has a market cap of $338.99 million, a P/E ratio of 13.75 and a beta of 0.47.
National Research (NASDAQ:NRC - Get Free Report) last released its quarterly earnings data on Monday, January 27th. The company reported $0.28 EPS for the quarter. National Research had a net margin of 17.32% and a return on equity of 66.52%.
National Research Company Profile
(
Free Report)
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.
Further Reading
Before you consider National Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Research wasn't on the list.
While National Research currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
